People
-
CDMO Molecular Profiles says that it has hired Charles D. Maher as head of US sales in order to “increase awareness and uptake of its pharmaceutical development services in the North American market.” The company’s… Read more . . .
-
In anticipation of the potential commercialization of its Arikayce inhaled liposomal amikacin, Insmed has announced a number of management changes designed to “better align the organization with the company’s growth opportunities.” Those changes are: Renu… Read more . . .
-
The FDA has announced a funding opportunity for a research project titled “Development of Clinically Relevant In Vitro Performance Test for Generic OIDPs: Physiologically Relevant Models for Aerodynamic Particle Size Distribution Analysis.” Two grants of… Read more . . .
-
3M Drug Delivery Systems has announced that Cindy R. Kent has succeeded James Ingebrand as President and General Manager, effective February 2014. Ingebrand will now head 3M’s dental division. Kent joined 3M in October 2013… Read more . . .
-
CDMO Formex, formerly PharmaForm, has hired Steve Massah as President and CEO. Massah joins Formex from Gilead, where he worked in Strategic Drug Product Manufacturing and Outsourcing. He has previously held management positions with Avanir,… Read more . . .
-
The New York Times has reported that Hunein “John” Maassab, who developed the FluMist intranasal live attenuated influenza vaccine (LAIV), died on February 1, 2014 in North Carolina. Dr. Maassab received a doctorate in epidemiology… Read more . . .
-
Alexza Pharmaceuticals has announced the hire of Robert A. Lippe as Executive VP, Operations and Chief Operations Officer. Lippe was most recently Head of Global Operations & Operational Excellence at Ironwood Pharmaceuticals. The company is… Read more . . .
-
Lupin Pharmaceuticals has announced that Maurice Chagnaud has joined the company as President, Europe and Head of Inhalation Strategy. He was most recently Senior Vice President, Central & Eastern Europe at Teva. Chagnaud’s responsibilities will… Read more . . .
-
Civitas Therapeutics has announced that former Sunovion CEO Mark Iwicki will succeed Glenn Batchelder as President and Chief Executive Officer. Iwicki was most recently CEO of Blend Therapeutics. According to Civitas, which is developing inhaled… Read more . . .
-
Advocacy organization Allergy & Asthma Network Mothers of Asthmatics (AANMA) has announced that Tonya Winders will take over as Chief Executive Officer as of January 1, 2014. She succeeds founder Nancy Sander, who retired in… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 10: SMI.London 2026, London, UK
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan